Article
Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency/X-linked lymphoproliferative disease type 1.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation - 1 Oct 2014
Marsh Rebecca A, Bleesing Jack J, Chandrakasan Shanmuganathan, Jordan Michael B, Davies Stella M, Filipovich Alexandra H
Abstract excerpt
X-linked lymphoproliferative disease type 1 (XLP1) is a rare immune deficiency caused by mutations in SH2D1A. Allogeneic hematopoietic cell transplantation (HCT) is often performed because of the morbidity and mortality associated with XLP1. There is limited experience using reduced-intensity con...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.